The symptoms of AD, such as scaling, excoriation, erythema, edema, epidermal thickness, infiltration of mast cell, serum levels of IgE, and spleen weight and lymph node length are decreased by treatment with ozonated HA-PO in an oxazolone (Oxz)-induced AD mouse model [79]. Here, IGHE is linked to Alzheimer disease.